CSPC Pharmaceutical Group Limited (FRA:CVG)

CSPC Pharmaceutical Group Statistics

Total Valuation

FRA:CVG has a market cap or net worth of EUR 10.41 billion. The enterprise value is 9.48 billion.

Market Cap	10.41B
Enterprise Value	9.48B

Important Dates

The next estimated earnings date is Friday, November 21, 2025.

Earnings Date	Nov 21, 2025
Ex-Dividend Date	Oct 17, 2025

Share Statistics

Current Share Class	11.43B
Shares Outstanding	n/a
Shares Change (YoY)	-2.62%
Shares Change (QoQ)	-0.27%
Owned by Insiders (%)	24.76%
Owned by Institutions (%)	27.01%
Float	7.85B

Valuation Ratios

The trailing PE ratio is 22.71 and the forward PE ratio is 15.89.

PE Ratio	22.71
Forward PE	15.89
PS Ratio	3.37
PB Ratio	2.51
P/TBV Ratio	2.88
P/FCF Ratio	23.49
P/OCF Ratio	13.90
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 14.20, with an EV/FCF ratio of 21.40.

EV / Earnings	20.69
EV / Sales	3.00
EV / EBITDA	14.20
EV / EBIT	18.63
EV / FCF	21.40

Financial Position

The company has a current ratio of 2.24, with a Debt / Equity ratio of 0.01.

Current Ratio	2.24
Quick Ratio	1.93
Debt / Equity	0.01
Debt / EBITDA	0.09
Debt / FCF	0.13
Interest Coverage	97.82

Financial Efficiency

Return on equity (ROE) is 10.83% and return on invested capital (ROIC) is 7.34%.

Return on Equity (ROE)	10.83%
Return on Assets (ROA)	5.65%
Return on Invested Capital (ROIC)	7.34%
Return on Capital Employed (ROCE)	11.82%
Revenue Per Employee	160,397
Profits Per Employee	23,787
Employee Count	21,400
Asset Turnover	0.55
Inventory Turnover	2.65

Taxes

In the past 12 months, FRA:CVG has paid 122.89 million in taxes.

Income Tax	122.89M
Effective Tax Rate	21.12%

Stock Price Statistics

The stock price has increased by +27.87% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+27.87%
50-Day Moving Average	1.08
200-Day Moving Average	0.81
Relative Strength Index (RSI)	38.03
Average Volume (20 Days)	1,401

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:CVG had revenue of EUR 3.09 billion and earned 458.27 million in profits. Earnings per share was 0.04.

Revenue	3.09B
Gross Profit	2.06B
Operating Income	504.04M
Pretax Income	581.86M
Net Income	458.27M
EBITDA	638.92M
EBIT	504.04M
Earnings Per Share (EPS)	0.04

Balance Sheet

The company has 1.15 billion in cash and 58.84 million in debt, giving a net cash position of 1.09 billion.

Cash & Cash Equivalents	1.15B
Total Debt	58.84M
Net Cash	1.09B
Net Cash Per Share	n/a
Equity (Book Value)	4.14B
Book Value Per Share	0.35
Working Capital	1.49B

Cash Flow

In the last 12 months, operating cash flow was 748.43 million and capital expenditures -305.38 million, giving a free cash flow of 443.04 million.

Operating Cash Flow	748.43M
Capital Expenditures	-305.38M
Free Cash Flow	443.04M
FCF Per Share	n/a

Margins

Gross margin is 66.75%, with operating and profit margins of 16.31% and 14.83%.

Gross Margin	66.75%
Operating Margin	16.31%
Pretax Margin	18.83%
Profit Margin	14.83%
EBITDA Margin	20.68%
EBIT Margin	16.31%
FCF Margin	14.34%

Dividends & Yields

This stock pays an annual dividend of 0.03, which amounts to a dividend yield of 2.79%.

Dividend Per Share	0.03
Dividend Yield	2.79%
Dividend Growth (YoY)	-24.89%
Years of Dividend Growth	3
Payout Ratio	44.14%
Buyback Yield	2.62%
Shareholder Yield	5.42%
Earnings Yield	4.40%
FCF Yield	4.26%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on October 15, 2020. It was a forward split with a ratio of 1.6.

Last Split Date	Oct 15, 2020
Split Type	Forward
Split Ratio	1.6

Scores

FRA:CVG has an Altman Z-Score of 5.25 and a Piotroski F-Score of 4.

Altman Z-Score	5.25
Piotroski F-Score	4